ImmunityBio Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio126.775388.888648.472589.53
P/B Ratio-3.83-5.72-4.61-9.92
Enterprise Value Ratios
EV/Revenue187.096241.2011149.272870.55
Profitability & Returns
Return on Assets (ROA)-0.48%-0.52%-0.53%-0.57%-0.73%
Return on Capital Employed (ROCE)-1.05%-0.81%2.53%-3.18%-1.31%
Leverage & Solvency Ratios
Debt/Equity-1.62-1.51-1.61-2.66-2.33
Liquidity Ratios
Current Ratio3.365.050.280.911.64
Quick Ratio2.774.630.220.861.44
Efficiency Ratios
Asset Turnover0.030.000.000.000.00
Yield & Distribution Ratios
Earnings Yield-0.22%-0.17%-0.20%-0.14%
FCF Yield-0.21%-0.12%-0.20%-0.13%
Buyback Yield-0.38%-0.27%-0.03%-0.03%-0.03%